Endovia Health Sciences, Inc.
EDVA
24 hedge funds and large institutions have $7.96M invested in Endovia Health Sciences, Inc. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
1,545% more capital invested
Capital invested by funds: $484K → $7.96M (+$7.48M)
333% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 3
81% more call options, than puts
Call options by funds: $1.61M | Put options by funds: $892K
71% more funds holding
Funds holding: 14 → 24 (+10)
0.04% more ownership
Funds ownership: 0.01% → 0.05% (+0.04%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.55M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$867K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$628K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$391K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$367K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$68K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$63.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$35.2K |
| 4 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$31.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$19K |
EDVA Hedge Fund Activity: Q1 2022 in Review
24 of the 6,359 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q1 2022, worth a combined $7.96M — up 1,545% from $484K a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new EDVA positions and 3 closed out — a net gain of 10 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $4.55M. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $68K sold.
- 24 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q1 2022, up from 14 in Q4 2021.
- Funds reported $7.96M of Endovia Health Sciences, Inc. stock for Q1 2022, up 1,545% quarter-over-quarter.
- 13 funds opened new Endovia Health Sciences, Inc. positions in Q1 2022 and 3 closed out, a net change of +10 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q1 2022 was Vanguard Group, an estimated $4.55M added.
- The largest Endovia Health Sciences, Inc. seller in Q1 2022 was FNY Investment Advisers, an estimated $68K sold.
Based on aggregated 13F filings for Q1 2022.